BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210603T153000
DTEND;TZID=America/Vancouver:20210603T160000
DTSTAMP:20260721T210817
CREATED:20210527T224528Z
LAST-MODIFIED:20210527T224528Z
UID:13018-1622734200-1622736000@scienceinseattle.com
SUMMARY:New Faces Seminar: Dr. Rachel Bender-Ignacio
DESCRIPTION:Start Date and Time\nJune 3\, 2021 – 3:30pm\n\n\nEnd Date and Time\nJune 3\, 2021 – 4:00pm\n\n\nSpeaker: Rachel Bender-Ignacio\, MD\, MPH \nAffiliation: University of Washington \nTalk Title: Mycobacterium tuberculosis infection\, associated immune activation \, and risk of acquiring HIV \nZoom – https://washington.zoom.us/j/91256320491 \n \nRachel Bender Ignacio is an infectious disease physician-scientist and Assistant Professor at the University of Washington\, where she recently was named the Director of the UW AIDS Clinical Trials Unit.  She completed medical school and an MPH in epidemiology at the UW. She trained in Internal Medicine at at Mass General Hospital/Harvard and was briefly on faculty there prior to returning to UW for Infectious Diseases fellowship. The majority of her patient care and research has been focused on HIV\, co-infections\, and malignancies\, specifically on the intersection with co-infections\, immune activation\, and HIV outcomes Dr. Bender Ignacio is currently a Director on the HIV Medicine Association Board.   Since the beginning of the COVID-19 pandemic\, she has also taken on significant leadership on COVID-19 treatment research\, including serving as the Medical Director of the COVID-19 Clinical Research Center at the Fred Hutch\, and as a protocol lead of the international ACTIV-2 study (riseabovecovid.org).  The work discussed today is the result of a recently completed CFAR New Investigator Award\, granted in 2018.
URL:https://scienceinseattle.com/event/new-faces-seminar-dr-rachel-bender-ignacio/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210603T153000
DTEND;TZID=America/Vancouver:20210603T160000
DTSTAMP:20260721T210817
CREATED:20210527T224528Z
LAST-MODIFIED:20210527T224528Z
UID:25743-1622734200-1622736000@scienceinseattle.com
SUMMARY:New Faces Seminar: Dr. Rachel Bender-Ignacio
DESCRIPTION:Start Date and Time\nJune 3\, 2021 – 3:30pm\n\n\nEnd Date and Time\nJune 3\, 2021 – 4:00pm\n\n\nSpeaker: Rachel Bender-Ignacio\, MD\, MPH \nAffiliation: University of Washington \nTalk Title: Mycobacterium tuberculosis infection\, associated immune activation \, and risk of acquiring HIV \nZoom – https://washington.zoom.us/j/91256320491 \n \nRachel Bender Ignacio is an infectious disease physician-scientist and Assistant Professor at the University of Washington\, where she recently was named the Director of the UW AIDS Clinical Trials Unit.  She completed medical school and an MPH in epidemiology at the UW. She trained in Internal Medicine at at Mass General Hospital/Harvard and was briefly on faculty there prior to returning to UW for Infectious Diseases fellowship. The majority of her patient care and research has been focused on HIV\, co-infections\, and malignancies\, specifically on the intersection with co-infections\, immune activation\, and HIV outcomes Dr. Bender Ignacio is currently a Director on the HIV Medicine Association Board.   Since the beginning of the COVID-19 pandemic\, she has also taken on significant leadership on COVID-19 treatment research\, including serving as the Medical Director of the COVID-19 Clinical Research Center at the Fred Hutch\, and as a protocol lead of the international ACTIV-2 study (riseabovecovid.org).  The work discussed today is the result of a recently completed CFAR New Investigator Award\, granted in 2018.
URL:https://scienceinseattle.com/event/new-faces-seminar-dr-rachel-bender-ignacio-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210603T153000
DTEND;TZID=America/Vancouver:20210603T160000
DTSTAMP:20260721T210817
CREATED:20210527T224528Z
LAST-MODIFIED:20210527T224528Z
UID:26708-1622734200-1622736000@scienceinseattle.com
SUMMARY:New Faces Seminar: Dr. Rachel Bender-Ignacio
DESCRIPTION:Start Date and Time\nJune 3\, 2021 – 3:30pm\n\n\nEnd Date and Time\nJune 3\, 2021 – 4:00pm\n\n\nSpeaker: Rachel Bender-Ignacio\, MD\, MPH \nAffiliation: University of Washington \nTalk Title: Mycobacterium tuberculosis infection\, associated immune activation \, and risk of acquiring HIV \nZoom – https://washington.zoom.us/j/91256320491 \n \nRachel Bender Ignacio is an infectious disease physician-scientist and Assistant Professor at the University of Washington\, where she recently was named the Director of the UW AIDS Clinical Trials Unit.  She completed medical school and an MPH in epidemiology at the UW. She trained in Internal Medicine at at Mass General Hospital/Harvard and was briefly on faculty there prior to returning to UW for Infectious Diseases fellowship. The majority of her patient care and research has been focused on HIV\, co-infections\, and malignancies\, specifically on the intersection with co-infections\, immune activation\, and HIV outcomes Dr. Bender Ignacio is currently a Director on the HIV Medicine Association Board.   Since the beginning of the COVID-19 pandemic\, she has also taken on significant leadership on COVID-19 treatment research\, including serving as the Medical Director of the COVID-19 Clinical Research Center at the Fred Hutch\, and as a protocol lead of the international ACTIV-2 study (riseabovecovid.org).  The work discussed today is the result of a recently completed CFAR New Investigator Award\, granted in 2018.
URL:https://scienceinseattle.com/event/new-faces-seminar-dr-rachel-bender-ignacio-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210603T160000
DTEND;TZID=America/Vancouver:20210603T170000
DTSTAMP:20260721T210817
CREATED:20210527T224629Z
LAST-MODIFIED:20210531T180305Z
UID:13020-1622736000-1622739600@scienceinseattle.com
SUMMARY:CFAR Seminar: Dr. Nicole Doria-Rose
DESCRIPTION:Start Date and Time\nJune 3\, 2021 – 4:00pm\n\n\nEnd Date and Time\nJune 3\, 2021 – 5:00pm\n\n\nCFAR Seminar Speaker: Nicole Doria- Rose\, PhD \nAffiliation: National Institutes of Health \nTalk Title: HIV Neutralizing Antibody CAP256V2LS: From Sorting B Cells To Filling Vials \nZoom – https://washington.zoom.us/j/91256320491 \n \nNicole Doria-Rose\, PhD is Chief of the Humoral Immunology Core at the Vaccine Research Center\, National Institutes of Health\, USA. She obtained her PhD from Cornell University in 1998 followed by post-doctoral work at the Seattle Biomedical Research Institute and the Department of Pathobiology at UW. Her research focus is the identification and characterization of broadly neutralizing antibodies from HIV-infected patients\, with an emphasis on patients followed from the time of infection. She developed a high-throughput method for culturing and screening single B cells for antibody discovery\, and with this method her team isolated the most potently HIV-neutralizing antibody yet known. At the Vaccine Research Center\, she leads a program that evaluates the immune responses to HIV-1 infection and to novel immunogens\, and investigates the clinical use of broadly neutralizing antibodies for prevention of HIV-1. She also led a team to develop a neutralization assay for SARS-CoV-2\, the virus that causes COVID-19\, and provided data in support of the mRNA vaccines now in use worldwide.
URL:https://scienceinseattle.com/event/cfar-seminar-dr-nicole-doria-rose/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210603T160000
DTEND;TZID=America/Vancouver:20210603T170000
DTSTAMP:20260721T210817
CREATED:20210527T224629Z
LAST-MODIFIED:20210527T224629Z
UID:25744-1622736000-1622739600@scienceinseattle.com
SUMMARY:CFAR Seminar: Dr. Nicole Doria-Rose
DESCRIPTION:Start Date and Time\nJune 3\, 2021 – 4:00pm\n\n\nEnd Date and Time\nJune 3\, 2021 – 5:00pm\n\n\nCFAR Seminar Speaker: Nicole Doria- Rose\, PhD \nAffiliation: National Institutes of Health \nTalk Title: HIV Neutralizing Antibody CAP256V2LS: From Sorting B Cells To Filling Vials \nZoom – https://washington.zoom.us/j/91256320491 \n \nNicole Doria-Rose\, PhD is Chief of the Humoral Immunology Core at the Vaccine Research Center\, National Institutes of Health\, USA. She obtained her PhD from Cornell University in 1998 followed by post-doctoral work at the Seattle Biomedical Research Institute and the Department of Pathobiology at UW. Her research focus is the identification and characterization of broadly neutralizing antibodies from HIV-infected patients\, with an emphasis on patients followed from the time of infection. She developed a high-throughput method for culturing and screening single B cells for antibody discovery\, and with this method her team isolated the most potently HIV-neutralizing antibody yet known. At the Vaccine Research Center\, she leads a program that evaluates the immune responses to HIV-1 infection and to novel immunogens\, and investigates the clinical use of broadly neutralizing antibodies for prevention of HIV-1. She also led a team to develop a neutralization assay for SARS-CoV-2\, the virus that causes COVID-19\, and provided data in support of the mRNA vaccines now in use worldwide.
URL:https://scienceinseattle.com/event/cfar-seminar-dr-nicole-doria-rose-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210603T160000
DTEND;TZID=America/Vancouver:20210603T170000
DTSTAMP:20260721T210817
CREATED:20210527T224629Z
LAST-MODIFIED:20210527T224629Z
UID:26709-1622736000-1622739600@scienceinseattle.com
SUMMARY:CFAR Seminar: Dr. Nicole Doria-Rose
DESCRIPTION:Start Date and Time\nJune 3\, 2021 – 4:00pm\n\n\nEnd Date and Time\nJune 3\, 2021 – 5:00pm\n\n\nCFAR Seminar Speaker: Nicole Doria- Rose\, PhD \nAffiliation: National Institutes of Health \nTalk Title: HIV Neutralizing Antibody CAP256V2LS: From Sorting B Cells To Filling Vials \nZoom – https://washington.zoom.us/j/91256320491 \n \nNicole Doria-Rose\, PhD is Chief of the Humoral Immunology Core at the Vaccine Research Center\, National Institutes of Health\, USA. She obtained her PhD from Cornell University in 1998 followed by post-doctoral work at the Seattle Biomedical Research Institute and the Department of Pathobiology at UW. Her research focus is the identification and characterization of broadly neutralizing antibodies from HIV-infected patients\, with an emphasis on patients followed from the time of infection. She developed a high-throughput method for culturing and screening single B cells for antibody discovery\, and with this method her team isolated the most potently HIV-neutralizing antibody yet known. At the Vaccine Research Center\, she leads a program that evaluates the immune responses to HIV-1 infection and to novel immunogens\, and investigates the clinical use of broadly neutralizing antibodies for prevention of HIV-1. She also led a team to develop a neutralization assay for SARS-CoV-2\, the virus that causes COVID-19\, and provided data in support of the mRNA vaccines now in use worldwide.
URL:https://scienceinseattle.com/event/cfar-seminar-dr-nicole-doria-rose-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210603T170000
DTEND;TZID=America/Vancouver:20210603T180000
DTSTAMP:20260721T210817
CREATED:20210521T161641Z
LAST-MODIFIED:20210521T161641Z
UID:12924-1622739600-1622743200@scienceinseattle.com
SUMMARY:GU Oncology Seminar Series
DESCRIPTION:The Genitourinary (GU) Oncology Seminar Series offers a weekly seminar featuring lectures by Fred Hutch\, UW\, and external scientists to share their latest developments and recent research. This series is hosted jointly by the PNW Prostate SPORE\, Program in Prostate Cancer Research (PPCR)\, and Bladder Cancer Group (BCG). \nLivestream:  https://us02web.zoom.us/j/85023704247\nFeedback form for speaker: https://ppcrspore.formstack.com/forms/ppcr_feedback \nView past seminar recordings \n\n\n\n\n\nDate:\nThursday\, June 03\, 2021\n\n\nStart Time:\n5 p.m. PDT\n\n\nHost or Sponsor:\nPacific Northwest Prostate Cancer SPORE\n\n\nLocation:\nVirtual\n\n\nSpeaker or Presenter:\nMichael Haffner\, MD\, PhD\n\n\nContact Information:\nPPCR_SPOREadmin@fredhutch.org
URL:https://scienceinseattle.com/event/gu-oncology-seminar-series-11/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210603T170000
DTEND;TZID=America/Vancouver:20210603T180000
DTSTAMP:20260721T210817
CREATED:20210521T161641Z
LAST-MODIFIED:20210521T161641Z
UID:25735-1622739600-1622743200@scienceinseattle.com
SUMMARY:GU Oncology Seminar Series
DESCRIPTION:The Genitourinary (GU) Oncology Seminar Series offers a weekly seminar featuring lectures by Fred Hutch\, UW\, and external scientists to share their latest developments and recent research. This series is hosted jointly by the PNW Prostate SPORE\, Program in Prostate Cancer Research (PPCR)\, and Bladder Cancer Group (BCG). \nLivestream:  https://us02web.zoom.us/j/85023704247\nFeedback form for speaker: https://ppcrspore.formstack.com/forms/ppcr_feedback \nView past seminar recordings \n\n\n\n\n\nDate:\nThursday\, June 03\, 2021\n\n\nStart Time:\n5 p.m. PDT\n\n\nHost or Sponsor:\nPacific Northwest Prostate Cancer SPORE\n\n\nLocation:\nVirtual\n\n\nSpeaker or Presenter:\nMichael Haffner\, MD\, PhD\n\n\nContact Information:\nPPCR_SPOREadmin@fredhutch.org
URL:https://scienceinseattle.com/event/gu-oncology-seminar-series-11-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210603T170000
DTEND;TZID=America/Vancouver:20210603T180000
DTSTAMP:20260721T210817
CREATED:20210521T161641Z
LAST-MODIFIED:20210521T161641Z
UID:26700-1622739600-1622743200@scienceinseattle.com
SUMMARY:GU Oncology Seminar Series
DESCRIPTION:The Genitourinary (GU) Oncology Seminar Series offers a weekly seminar featuring lectures by Fred Hutch\, UW\, and external scientists to share their latest developments and recent research. This series is hosted jointly by the PNW Prostate SPORE\, Program in Prostate Cancer Research (PPCR)\, and Bladder Cancer Group (BCG). \nLivestream:  https://us02web.zoom.us/j/85023704247\nFeedback form for speaker: https://ppcrspore.formstack.com/forms/ppcr_feedback \nView past seminar recordings \n\n\n\n\n\nDate:\nThursday\, June 03\, 2021\n\n\nStart Time:\n5 p.m. PDT\n\n\nHost or Sponsor:\nPacific Northwest Prostate Cancer SPORE\n\n\nLocation:\nVirtual\n\n\nSpeaker or Presenter:\nMichael Haffner\, MD\, PhD\n\n\nContact Information:\nPPCR_SPOREadmin@fredhutch.org
URL:https://scienceinseattle.com/event/gu-oncology-seminar-series-11-3/
LOCATION:Online
END:VEVENT
END:VCALENDAR